Feb 2014 $20 M No. 6 $10 to $50 million 15
Regado Biosciences Inc: Raise no. 6, Feb 2014 × Investors in this round 15 investors had bought by the notice of Feb 25, 2014: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,200,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chris J. Courts · Executive Officer · Vice President of Finance David J. Mazzo · Executive Officer, Director · Chief Executive Officer Michael J. Metzger · Executive Officer · Chief Operating Officer & President Anton J. Gopka · Director B. Jefferson Clark · Director Dennis J. Podlesak · Director · Chairman of the Board Jesse J. Treu · Director Michael J. Mendelsohn · Director P. Sherrill Neff · Director Pierre J. Legault · Director Raphael Jefferson Wisniewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round BMO Capital Markets Corp. (CRD 16686) · New York, New York Sold in all US states Cowen and Company, LLC (CRD 7616) · New York, New York Sold in all US states Remarks in the notice On fees: “Placement Agent fees equal to 6% of gross proceeds.”Signed by David J. Mazzo, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 25, 2014. Read the notice at the SEC .
equity SEC Dec 2012 $23 M No. 5 $10 to $50 million 8
Regado Biosciences Inc: Raise no. 5, Dec 2012 × Investors in this round 8 investors had bought by the notice of Jan 17, 2013: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $23 M of $51 M offered; $28 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Notes are being converted into preferred stock
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J Mazzo · Executive Officer, Director · President and Chief Executive Officer Dennis J. Podlesak · Executive Officer, Director · Chairman of the Board Anton J. Gopka · Director B. Jefferson Clark · Director Jesse J Treu · Director P. Sherrill Neff · Director Raphael Jefferson Wishiewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David J. Mazzo, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 17, 2013. Read the notice at the SEC .
equity SEC May 2012 $7 M No. 4 $2 to $10 million 6
Regado Biosciences Inc: Raise no. 4, May 2012 × Investors in this round 6 investors had bought by the notice of May 21, 2012: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $7 M of $14 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Notes convertible into preferred stock
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J Mazzo · Executive Officer, Director · President and Chief Executive Officer Dennis Sherrill Podlesak · Executive Officer, Director · Chairman of the Board Jeff Sherrill Clark · Director Jesse J Treu · Director P. Sherrill Neff · Director Raphael Sherrill Wishiewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David J. Mazzo, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 21, 2012. Read the notice at the SEC .
equity, debt SEC May 2011 $12 M No. 3 $10 to $50 million 8
Regado Biosciences Inc: Raise no. 3, May 2011 × Investors in this round 8 investors had bought by the notice of Jul 1, 2011: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $12 M of $12 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series D Preferred Stock
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J Mazzo · Executive Officer, Director · President and Chief Executive Officer Dennis Sherrill Podlesak · Executive Officer, Director · Chairman of the Board Jeff Sherrill Clark · Director Jesse J Treu · Director P. Sherrill Neff · Director Raphael Sherrill Wishiewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David J. Mazzo, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 1, 2011. Read the notice at the SEC .
equity SEC Mar 2010 $40 M No. 2 $10 to $50 million 8
Regado Biosciences Inc: Raise no. 2, Mar 2010 × Investors in this round 8 investors had bought by the notice of Jul 1, 2011: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $40 M of $40 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series D Preferred Stock
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J Mazzo · Executive Officer, Director · President and Chief Executive Officer Dennis Sherrill Podlesak · Executive Officer, Director · Chairman of the Board Jeff Sherrill Clark · Director Jesse J Treu · Director P. Sherrill Neff · Director Raphael Sherrill Wishiewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David J. Mazzo, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 1, 2011. Read the notice at the SEC .
equity SEC Dec 2009 $26 M No. 1 $10 to $50 million 8
Regado Biosciences Inc: Raise no. 1, Dec 2009 × Investors in this round 8 investors had bought by the notice of Jun 30, 2011: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Regado Biosciences Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $26 M of $26 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series D Preferred Stock
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David J Mazzo · Executive Officer, Director · President and Chief Executive Officer Dennis Sherrill Podlesak · Executive Officer, Director · Chairman of the Board Jeff Sherrill Clark · Director Jesse J Treu · Director P. Sherrill Neff · Director Raphael Sherrill Wishiewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David J. Mazzo, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 30, 2011. Read the notice at the SEC .
equity SEC